Our publications related to cancer biomarkers

Found 14 results
Filters: First Letter Of Last Name is S  [Clear All Filters]
Journal Article
Menyhart O, Budczies J, Munkácsy G, Esteva FJ, Szabó A, Miquel TP, Győrffy B.  2017.  DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
Győrffy B, Karn T, Sztupinszki Z, Weltz B, Müller V, Pusztai L.  2015.  Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.. Int J Cancer. 136(9):2091-8.
Gyorffy B., Molnar B., Lage H., Szallasi Z., Eklund A.C.  2009.  Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One. 4:e5645.
Li Q., Birkbak N.J, Gyorffy B., Szallasi Z., Eklund A.C.  2011.  Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics. 12:474.
Gyorffy B., Schafer R..  2009.  Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Breast Cancer Res Treat. 118:433-41.
Gyorffy B., Benke Z., Lanczky A., Balazs B., Szallasi Z., Timar J., Schafer R..  2012.  RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat. 132:1025-34.
Gyorffy B., Benke Z., Lanczky A., Balazs B., Szallasi Z., Timar J., Schafer R..  2012.  RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat. 132:1025-34.
Győrffy B, Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H et al..  2014.  TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.. Mol Oncol. 8(3):508-19.
Győrffy B, Bottai G, Lehmann-Che J, Kéri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de Thè H et al..  2014.  TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.. Mol Oncol. 8(3):508-19.
Pongor L, Kormos M, Hatzis C, Pusztai L, Szabó A, Győrffy B.  2015.  A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients.. Genome Med. 7(1):104.

Pages